Annual report pursuant to Section 13 and 15(d)

Note 14 - Income Taxes - Components of Deferred Tax Assets (Details)

v3.23.1
Note 14 - Income Taxes - Components of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Net operating loss carryforwards $ 39,200,586 $ 36,793,074
R&D credit carryforwards [1] 9,256,968 9,501,299
Stock compensation 286,724 481,098
Intangibles 455,959 567,213
Accrued expenses 710,940 0
Capitalized §174 expenses 1,116,433 0
Disallowed interest expense 0 851,247
Temporary differences 196,575 305,974
Deferred tax assets before valuation allowance 51,224,185 48,499,905
Valuation allowance (51,224,185) (48,499,905)
Net deferred tax assets $ 0 $ 0
[1] Includes U.S. R&D credit carryforwards of $8,868,343 and state R&D credit carryforwards of $388,625 as of December 31, 2022.